Posted at 2022-10-19
Perspectives on lecanemab, the monoclonal antibody treatment for Alzheimer’s disease
Drugmakers Biogen Inc. (BIIB) and Eisai Co., Ltd. (ESALY) announced thatlecanemab, a monoclonal antibody treatment for Alzheimer’s disease, slows cognitive decline. Tegus was the most efficient way for investors to quickly understand Biogen and Eisai’s p…